Literature DB >> 33518184

Polycystic Ovary Syndrome: Ontogeny in Adolescence.

Christine M Burt Solorzano1, Christopher R McCartney2.   

Abstract

The pathophysiology of symptomatic polycystic ovary syndrome (PCOS) often unfolds across puberty, but the ontogeny of PCOS is difficult to study because, in general, its pathophysiology is well entrenched before the diagnosis can be confirmed. However, the study of high-risk groups (daughters of women with PCOS, girls with premature pubarche, and girls with obesity) can offer insight in this regard. Available data support the hypothesis that the pubertal development of PCOS involves various combinations of genetic predisposition, intrauterine programming, hyperinsulinism, and numerous other abnormalities that provoke reproductive symptoms (eg, hyperandrogenism, ovulatory dysfunction) in response to the pubertal increase in gonadotropin secretion.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Daughters; Hyperandrogenemia; Hyperandrogenism; Obesity; PCOS; Premature adrenarche; Premature pubarche; Puberty

Mesh:

Year:  2021        PMID: 33518184      PMCID: PMC7864394          DOI: 10.1016/j.ecl.2020.10.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  71 in total

1.  Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.

Authors:  Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Maria Victoria Marcos; Francis de Zegher
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

2.  Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing.

Authors:  L Ibáñez; N Potau; M Zampolli; M E Street; A Carrascosa
Journal:  Fertil Steril       Date:  1997-05       Impact factor: 7.329

3.  Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants.

Authors:  Karen L Knudsen; Susan K Blank; Christine Burt Solorzano; James T Patrie; R Jeffrey Chang; Sonia Caprio; John C Marshall; Christopher R McCartney
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

4.  Anovulation after precocious pubarche: early markers and time course in adolescence.

Authors:  L Ibáñez; F de Zegher; N Potau
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

Review 5.  Childhood obesity and its impact on the development of adolescent PCOS.

Authors:  Amy D Anderson; Christine M Burt Solorzano; Christopher R McCartney
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

6.  Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche.

Authors:  L Ibáñez; N Potau; P Chacon; C Pascual; A Carrascosa
Journal:  Diabetologia       Date:  1998-09       Impact factor: 10.122

7.  Insulin Resistance, Hyperinsulinemia, and LH: Relative Roles in Peripubertal Obesity-Associated Hyperandrogenemia.

Authors:  Christine M Burt Solorzano; Karen L Knudsen; Amy D Anderson; Eleanor G Hutchens; Jessicah S Collins; James T Patrie; John C Marshall; Christopher R McCartney
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

8.  Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism.

Authors:  L Ibañez; N Potau; R Virdis; M Zampolli; C Terzi; M Gussinyé; A Carrascosa; E Vicens-Calvet
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

9.  The impact of obesity on hyperandrogenemia in Korean girls.

Authors:  Min Jae Kang; Seung Yang; Il Tae Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-12-31

10.  Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.

Authors:  Felix R Day; David A Hinds; Joyce Y Tung; Lisette Stolk; Unnur Styrkarsdottir; Richa Saxena; Andrew Bjonnes; Linda Broer; David B Dunger; Bjarni V Halldorsson; Debbie A Lawlor; Guillaume Laval; Iain Mathieson; Wendy L McCardle; Yvonne Louwers; Cindy Meun; Susan Ring; Robert A Scott; Patrick Sulem; André G Uitterlinden; Nicholas J Wareham; Unnur Thorsteinsdottir; Corrine Welt; Kari Stefansson; Joop S E Laven; Ken K Ong; John R B Perry
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

View more
  3 in total

1.  The risk factors of gestational diabetes mellitus in patients with polycystic ovary syndrome: What should we care.

Authors:  Xiaocui Li; Xinru Liu; Yan Zuo; Jiejun Gao; Yan Liu; Wei Zheng
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

Review 2.  The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome.

Authors:  Christopher R McCartney; Rebecca E Campbell; John C Marshall; Suzanne M Moenter
Journal:  J Neuroendocrinol       Date:  2022-01-26       Impact factor: 3.870

Review 3.  Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.

Authors:  Valeria Calcaterra; Elvira Verduci; Hellas Cena; Vittoria Carlotta Magenes; Carolina Federica Todisco; Elisavietta Tenuta; Cristina Gregorio; Rachele De Giuseppe; Alessandra Bosetti; Elisabetta Di Profio; Gianvincenzo Zuccotti
Journal:  Nutrients       Date:  2021-05-28       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.